SGYP.OB: Summary for SYNERGY PHARMACEUTCL - Yahoo! Canada Finance

SYNERGY PHARMACEUTCL (OTC BB:SGYP.OB) Delayed quote data

Last Trade:	4.50 USD
Trade Time:	Nov 24
Change:	0.09 (1.96%)
Prev Close:	4.59
Open:	4.21
Bid:	4.05 x 500
Ask:	4.70 x 500
1y Target Est:	N/A

Day's Range:	3.95 - 4.50
52wk Range:	1.55 - 4.70
Volume:	1,000
Avg Vol (3m):	1,877.27
Market Cap:	340.82M
P/E (ttm):	N/A
EPS (ttm):	-0.50
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y

Add SGYP.OB to Portfolio

Download Data

HEADLINES

•	SYNERGY PHARMACEUTICALS, INC. Financials
	EDGAR Online Financials (Fri, Nov 20)

•	SYNERGY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Mon, Nov 16)

•	Synergy Pharmaceuticals Raises $8.6 Million in Common Stock Financing
	Business Wire (Thu, Nov 12)

•	SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure
	EDGAR Online (Mon, Nov 9)

•	SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Eq
	EDGAR Online (Thu, Nov 5)

•	SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure
	EDGAR Online (Fri, Oct 9)

•	SYNERGY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and
	EDGAR Online (Thu, Oct 8)

•	Synergy Pharmaceuticals Announces Appointment of Dr. Alan F. Joslyn to Board of Directors
	Business Wire (Thu, Oct 8)

•	Synergy Pharmaceuticals to Present at the 17th Annual BioPartnering Europe Conference in London, UK
	Business Wire (Mon, Oct 5)

•	SYNERGY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Fri, Aug 14)

More Headlines for SGYP.OB...

BUSINESS SUMMARY

Synergy Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses primarily on the development of drugs to treat gastrointestinal (GI) disorders and diseases.

Full Company Profile

Add to Portfolio

Email to a Friend

•

	Sign In [New User? Sign Up]	Finance Home \|Help

Synergy Pharmaceuticals, Inc. (SGYP.OB)